Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Signs and Symptoms of Anemia in Patients Over 75 Years

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02662699
Recruitment Status : Unknown
Verified May 2017 by University Hospital, Strasbourg, France.
Recruitment status was:  Recruiting
First Posted : January 25, 2016
Last Update Posted : May 19, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Anemia is a common pathology in geriatrics. According to the World Health Organization it affects 23.9% of subjects over 60 years in the world, and 8% of patients over 60 years in Europe. A prevalence that increases with the age and twice in individuals over 85 years.

Condition or disease
Anemia

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Clinical Signs and Symptoms of Anemia in Patients Over 75 Years
Actual Study Start Date : October 2016
Estimated Primary Completion Date : January 2018
Estimated Study Completion Date : January 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anemia

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Laboratory tests [ Time Frame: 1 hour after hospitalization ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   75 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Anemic patients
Criteria

Inclusion criteria:

  • Adult over 75 years old, male or female

Exclusion criteria:

  • Transfusion within 3 months, acute anemia / deglobulisation
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02662699


Contacts
Layout table for location contacts
Contact: Emmanuel ANDRES, MD, PhD 33 3 88 11 50 66 Emmanuel.ANDRES@chru-strasbourg.fr
Contact: Mohamed Hassanine BEN MALEK, MD 33 3 6 75 44 30 79 hassaninebenmalek@hotmail.fr

Locations
Layout table for location information
France
Service de Médecine Interne, diabète et maladies métaboliques - Médicale B Recruiting
Strasbourg, France, 67091
Contact: Emmanuel ANDRES, MD, PhD    33 3 88 11 50 66    emmanuel.andres@chru-strasbourg.fr   
Contact: Hassanine BEN MALEK, MD, PhD    33 6 75 44 30 79    hassaninebenmalek@hotmail.fr   
Principal Investigator: Emmanuel ANDRES, MD, PhD         
Sub-Investigator: Hassanine BEN MALEK, MD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Layout table for investigator information
Study Director: Emmanuel ANDRES University Hospital, Strasbourg, France
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT02662699    
Other Study ID Numbers: HUS n° 6247
First Posted: January 25, 2016    Key Record Dates
Last Update Posted: May 19, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
Anemia
Hematologic Diseases
Erythrocytes
Hemoglobin
Hemolytic
Additional relevant MeSH terms:
Layout table for MeSH terms
Anemia
Hematologic Diseases